Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹229 Cr
P/E Ratio
--
P/B Ratio
3.57
Industry P/E
36.11
Debt to Equity
0.07
ROE
-25.19 %
ROCE
-28.16 %
Div. Yield
0 %
Book Value
18.19
EPS
-3.48
CFO
₹-15.00 Cr
EBITDA
₹-24.44 Cr
Net Profit
₹-20.04 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
| -7.78 | -5.34 | -8.58 | 10.17 | 69.66 | 65.66 | 33.42 |
|
BSE Healthcare
| -6.54 | 1.91 | 4.84 | 19.10 | 20.06 | 22.35 | 10.14 |
|
BSE Small Cap
| -11.96 | 3.43 | 1.57 | 2.12 | 18.79 | 34.74 | 16.10 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Pharmaids Pharma
| 37.90 | 73.08 | 82.53 | -5.75 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 742.15 | 6,723.28 | 26.97 | 13.8 | |
| 524.45 | 8,278.92 | -- | 0.11 | |
| 1,090.30 | 8,919.62 | 73.49 | 12.96 | |
| 455.60 | 11,047.87 | 23.06 | 14.4 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1989
Chairman
Shankarappa Nagaraja Vinaya Babu
Managing Director
--
Headquarters
Bengaluru, Karnataka
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Pharmaids Pharmaceuticals Ltd stood at ₹ 95 Cr as on 31-Dec-24
The share price of Pharmaids Pharmaceuticals Ltd is ₹65.00 (BSE) as of 29-Apr-2025 IST. Pharmaids Pharmaceuticals Ltd has given a return of 69.66% in the last 3 years.
Pharmaids Pharmaceuticals Ltd has a market capitalisation of ₹ 229 Cr as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Pharmaids Pharmaceuticals Ltd is 3.57 times as on 29-Apr-2025, a 0% premium to its peers’ median range of 3.56 times.
Since, TTM earnings of Pharmaids Pharmaceuticals Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Pharmaids Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Pharmaids Pharmaceuticals Ltd.
Wholesale of pharmaceutical and medical goods
There is no promoters in Pharmaids Pharmaceuticals Ltd.
There is no promoter pledging in Pharmaids Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,968
|
|
|
8,743
|
|
|
8,351
|
|
|
6,661
|
| Pharmaids Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-17.62
|
|
Operating margin(%)
|
-82.62
|
|
Net Margin(%)
|
-73.04
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Pharmaids Pharmaceuticals Ltd was ₹-12 Cr.
₹-0.03
(
